- Dedication
- Preface
- Contributors
- Chapter 1 The Critically Ill Patient with Acute Kidney Injury
- Chapter 2 History and Rationale for Continuous Renal Replacement Therapy
- Chapter 3 Nomenclature for Renal Replacement Therapy in Acute Kidney Injury
- Chapter 4 Basic Principles of Solute Transport
- Chapter 5 Principles of Fluid Management in the Intensive Care Unit
- Chapter 6 Indications, Timing, and Patient Selection
- Chapter 7 Biomarkers for Initiation of Renal Replacement Therapy
- Chapter 8 Extended Indications
- Chapter 9 Dose Adequacy and Assessment
- Chapter 10 Acid–Base and Electrolyte Disorders
- Chapter 11 Choosing a Renal Replacement Therapy in Acute Kidney Injury
- Chapter 12 Vascular Access for Continuous Renal Replacement Therapy
- Chapter 13 The Circuit and the Prescription
- Chapter 14 The Membrane
- Chapter 15 Fluids for Continuous Renal Replacement Therapy
- Chapter 16 Alarms and Troubleshooting
- Chapter 17 Nonanticoagulation Strategies to Optimize Circuit Function in RRT
- Chapter 18 Anticoagulation
- Chapter 19 Regional Citrate Anticoagulation
- Chapter 20 Drug Dosing in Continuous Renal Replacement Therapy
- Chapter 21 Renal Replacement Therapy in Children
- Chapter 22 Therapeutic Plasma Exchange in Critical Care Medicine
- Chapter 23 MARS
- Chapter 24 Sorbents
- Chapter 25 Hybrid Therapies
- Chapter 26 The ICU Environment
- Chapter 27 Patient Care Quality and Teamwork
- Chapter 28 Organizational Aspects
- Chapter 29 Documentation, Billing, and Reimbursement for Continuous Renal Replacement Therapy
- Chapter 30 Machines for Continuous Renal Replacement Therapy
- Chapter 31 Quality Improvement for Continuous Renal Replacement Therapies
- Chapter 32 Educational Resources
- Glossary
- Index
(p. 193) Sorbents
- Chapter:
- (p. 193) Sorbents
- Author(s):
Dehua Gong
and Claudio Ronco
- DOI:
- 10.1093/med/9780190225537.003.0024
Endotoxin: Endotoxin is a lipopolysaccharide (LPS), and an outer membrane molecule essential for virtually all Gram-negative bacteria. It is generally considered a major causative agent in Gram-negative bacteria infection-related shock state. LPS will bind to LPS-binding protein(LBP) and be transferred to bind to surface molecule CD14 when it enters into blood, presented in aggregate form or monomeric form. The signal of LPS combination with CD14 will be relayed by toll-like receptor(TCR) to activate the nuclear factor κB(NF-κB) and produce multiple cytokines.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Dedication
- Preface
- Contributors
- Chapter 1 The Critically Ill Patient with Acute Kidney Injury
- Chapter 2 History and Rationale for Continuous Renal Replacement Therapy
- Chapter 3 Nomenclature for Renal Replacement Therapy in Acute Kidney Injury
- Chapter 4 Basic Principles of Solute Transport
- Chapter 5 Principles of Fluid Management in the Intensive Care Unit
- Chapter 6 Indications, Timing, and Patient Selection
- Chapter 7 Biomarkers for Initiation of Renal Replacement Therapy
- Chapter 8 Extended Indications
- Chapter 9 Dose Adequacy and Assessment
- Chapter 10 Acid–Base and Electrolyte Disorders
- Chapter 11 Choosing a Renal Replacement Therapy in Acute Kidney Injury
- Chapter 12 Vascular Access for Continuous Renal Replacement Therapy
- Chapter 13 The Circuit and the Prescription
- Chapter 14 The Membrane
- Chapter 15 Fluids for Continuous Renal Replacement Therapy
- Chapter 16 Alarms and Troubleshooting
- Chapter 17 Nonanticoagulation Strategies to Optimize Circuit Function in RRT
- Chapter 18 Anticoagulation
- Chapter 19 Regional Citrate Anticoagulation
- Chapter 20 Drug Dosing in Continuous Renal Replacement Therapy
- Chapter 21 Renal Replacement Therapy in Children
- Chapter 22 Therapeutic Plasma Exchange in Critical Care Medicine
- Chapter 23 MARS
- Chapter 24 Sorbents
- Chapter 25 Hybrid Therapies
- Chapter 26 The ICU Environment
- Chapter 27 Patient Care Quality and Teamwork
- Chapter 28 Organizational Aspects
- Chapter 29 Documentation, Billing, and Reimbursement for Continuous Renal Replacement Therapy
- Chapter 30 Machines for Continuous Renal Replacement Therapy
- Chapter 31 Quality Improvement for Continuous Renal Replacement Therapies
- Chapter 32 Educational Resources
- Glossary
- Index